Unibest

Pharmaceutical intermediates

Oliceridine Intermediates

1 pharmaceutical intermediate for Oliceridine. Indication: Acute pain.

提交项目All intermediates

About Oliceridine

Originator
Trevena Inc
Indication
Acute pain
Approved Date
10/30/2020
NCE Patent
10/30/2025
DS/DP
03/23/2032

Available intermediates

1 intermediate currently listed for Oliceridine. Request specifications, documentation or a quotation for any item below.

Oliceridine intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
3-Methoxythiophene-2-carbaldehyde35134-07-7//

Other programs under O

OfloxacinOlaparibOmadacycline toslateOrforglipronOSIMERTINIB MESYLATEOzenoxacin

Building toward Oliceridine?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →